Literature DB >> 9627744

Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls.

M Bloch1, P J Schmidt, T P Su, M B Tobin, D R Rubinow.   

Abstract

BACKGROUND: Premenstrual syndrome (PMS) is a cyclic mood disorder, widely believed, yet not conclusively shown, to be of endocrine etiology. This study examines basal levels of several hormones reported, albeit inconsistently, to differ in women with PMS compared with controls.
METHODS: Subjects (10 PMS patients and 10 controls) had their blood drawn for one full menstrual cycle. Subjects' mood and behavioral symptoms were assessed by daily self-ratings and objective ratings. Plasma was assayed for total and free testosterone (T), beta-endorphin (beta-EP), adrenocorticotropic hormone (ACTH), and cortisol.
RESULTS: No differences were observed between the PMS and control groups for beta-EP, ACTH, or cortisol. PMS subjects had significantly lower total and free T plasma levels with a blunting of the normal periovulatory peak, a finding that may be epiphenomenal to age.
CONCLUSIONS: This study does not confirm previous reports of abnormalities in plasma levels of either ACTH or beta-EP in women with PMS; it also fails to replicate a previous observation of high free T levels in women with PMS. These results are not supportive of a primary endocrine abnormality in PMS patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627744     DOI: 10.1016/s0006-3223(98)00403-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Emotion regulation in women with premenstrual dysphoric disorder.

Authors:  Nicole Petersen; Edythe D London; Letty Liang; Dara G Ghahremani; Rachel Gerards; Linda Goldman; Andrea J Rapkin
Journal:  Arch Womens Ment Health       Date:  2016-05-07       Impact factor: 3.633

2.  ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.

Authors:  Ellen E Lee; Lynnette K Nieman; Pedro E Martinez; Veronica L Harsh; David R Rubinow; Peter J Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

3.  Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Authors:  C Neill Epperson; Meir Steiner; S Ann Hartlage; Elias Eriksson; Peter J Schmidt; Ian Jones; Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

4.  Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Authors:  Rebecca R Klatzkin; Monica E Lindgren; Catherine A Forneris; Susan S Girdler
Journal:  Biol Psychol       Date:  2010-02-04       Impact factor: 3.251

5.  Sleep, Hormones, and Circadian Rhythms throughout the Menstrual Cycle in Healthy Women and Women with Premenstrual Dysphoric Disorder.

Authors:  Ari Shechter; Diane B Boivin
Journal:  Int J Endocrinol       Date:  2010-01-18       Impact factor: 3.257

Review 6.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

7.  Gonadal steroids, brain, and behavior: role of context.

Authors:  David R Rubinow; Peter J Schmidt
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986

8.  Does testosterone predict women's preference for facial masculinity?

Authors:  Urszula M Marcinkowska; Samuli Helle; Benedict C Jones; Grazyna Jasienska
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

9.  Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study.

Authors:  Somayeh Hashemi; Fahimeh Ramezani Tehrani; Nader Mohammadi; Marzieh Rostami Dovom; Farahnaz Torkestani; Masumeh Simbar; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2016-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.